Search is Powered by Google
Lymphoma / Leukemia News

Parents Blame Cigna For Transplant Daughter's Death, Despite Reversed Decision

rate icon Featured Article
Main Category: Lymphoma / Leukemia
Also Included In: Health Insurance / Medical Insurance;  Transplants / Organ Donations;  Liver Disease / Hepatitis
Article Date: 22 Dec 2007 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (8 votes)

Health Professional:4 stars

4 (5 votes)

Article Opinions: 3 posts

Nataline Sarkisyan, in California, needed a liver transplant in order to continue surviving her three-year battle against leukemia. The insurance company eventually agreed to cover her transplant, but not in time to save her life - Nataline died on Thursday, 20th December. Her parents say that Nataline would still be alive today if the insurance company had not taken so long to approve her transplant.

Despite a two-week battle with the insurance company to reverse their decision, Nataline's parents did not manage to get a positive decision in time. Krikor Sarkysyan, father, says that Cigna Corp., the health insurance company, took his daughter away from him. His lawyer, Mark Geragos, says he intends to sue the Cigna for inflicting emotional distress, plus some other allegations - he will ask the district attorney's office to press murder or manslaughter charges.

Whether a liver transplant can save a leukemia patient's life is not a clear issue among medical experts. Many say that the immunosuppressant drugs an organ transplant recipient must take may hasten the development of tumors.

Just before Thanksgiving Nataline had received a bone marrow transplant from her brother. Unfortunately, a complication ensued which brought about liver failure. She was taken off life support on 20th December and soon died - she was being treated at the University of California, Los Angeles, Medical Center.

Cigna had initially denied covering for a liver transplant for Nataline as it was classed as "experimental". However, four doctors appealed to the insurer - asking it to reconsider the decision. The doctors explained that 65% of patients who undergo such a transplant under similar circumstances survive for over six months. As a crowd of over 100 nurses and other people started to rally outside Cigna's Los Angeles offices, the company changed its mind and agreed to cover the costs of a transplant.

Nurses say that Nataline is one of many victims across the USA who suffers as a result of "draconian health insurance denial of care".

USA Top 13 Health Insurance and Managed Care Companies
(Fortune, April 30th, 2007 issue)

1. UnitedHealth Group
Revenue $71,542,000,000

2. Wellpoint
Revenue $56,953,000,000

3. Aetna
Revenue $25,568,600,000

4. Humana
Revenue $21,416,500,000

5. Cigna
Revenue $16,547,000,000

6. Health Net
Revenue $12,908,400,000

7. Coventry Health Care
Revenue $7,733,800,000

8. WellCare Health Plans
Revenue $3,762,900,000

9. Amerigroup
Revenue $2,835,100,000

10. Centene
Revenue $2,279,000,000

11. Medical Mutual of Ohio
Revenue $2,039,100,000

12. Molina Healthcare
Revenue $2,005,000,000

13. Sierra Health Services
Revenue $1,718,900,000

Written by - Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Case Of Patient "Cured" Of HIV Baffles Doctors
14 Nov 2008
Doctors and experts are baffled by the case of a 42-year old male American patient living in Berlin whose 10-year long HIV infection appears to have been "cured" by a bone marrow transplant given to treat his acute myeloid leukemia...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating Lymphoma Early image Treating Lymphoma Early

Non-Hodgkin's lymphoma is a cancer of the immune system. First-line treatment options include radiation therapy, chemotherapy, immunotherapy, radioimmunotherapy and stem cell transplant. How do you figure out which is right for you...

View more videos...